News

We are glad to share with you about the results of our work, company news, and give you timely developments and personnel appointment and removal conditions.
  • Xi’an DELI Biochemical Industry Co., Ltd., a professional manufacturer of cyclodextrin derivatives and pharmaceutical excipients, is pleased to announce its participation in two major international pharmaceutical exhibitions in Shanghai: API China 2026 and CPHI China 2026.

    2026-05-08

  • Cyclodextrin vs Hydroxypropyl Betadex: compare cost, solubility performance, safety, regulatory status and development timeline to choose the best excipient for pharmaceutical formulation optimization and drug delivery systems.

    2026-04-20

  • Vonoprazan Fumarate has emerged as a next-generation solution for managing acid-related gastrointestinal disorders. Unlike conventional therapies, it delivers rapid, consistent, and long-lasting acid suppression, addressing common patient concerns such as delayed symptom relief, incomplete healing, and nighttime acid breakthrough. This article provides a comprehensive exploration of its mechanism, benefits, applications, and practical considerations for buyers and healthcare stakeholders.

    2026-04-01

  • Hydroxypropyl Betadex (HPBCD) is a widely used pharmaceutical excipient known for improving the solubility, stability, and bioavailability of poorly water-soluble drugs. By forming inclusion complexes, it enhances drug performance across oral, injectable, and ophthalmic formulations. Its excellent compatibility and safety profile make it a key material in modern drug development. With reliable quality and stable supply, HPBCD supports pharmaceutical companies in optimizing formulations and accelerating product development for global markets.

    2026-03-30

  • Hydroxypropyl Betadex (HP-β-CD) is a versatile pharmaceutical excipient widely used in modern drug formulation. This article explores its properties, mechanisms of action, applications, and key advantages for improving solubility, stability, and bioavailability of active pharmaceutical ingredients (APIs). It also provides guidance on selection, handling, and regulatory considerations to help manufacturers optimize product development and reduce formulation challenges.

    2026-03-24

  • Hydroxypropyl Beta Cyclodextrin (HPβCD) is widely used across pharmaceutical, cosmetic, and industrial sectors due to its unique molecular structure and inclusion complex capabilities. This article explains how HPβCD enhances solubility, stability, and bioavailability of poorly soluble compounds, addressing key customer concerns such as formulation challenges, safety, and application efficiency.

    2026-03-18

icon
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept